{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:10:57Z","timestamp":1767831057513,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.bbrc.2020.09.142","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T09:58:27Z","timestamp":1602496707000},"page":"1269-1275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Sphingomyelin synthase 2 loss suppresses steatosis but exacerbates fibrosis in the liver of mice fed with choline-deficient, L-amino acid-defined, high-fat diet"],"prefix":"10.1016","volume":"533","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1439-4739","authenticated-orcid":false,"given":"Masayuki","family":"Sugimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3922-113X","authenticated-orcid":false,"given":"Tadateru","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Wakabayasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruyo","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshito","family":"Numata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Yukioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2020.09.142_bib1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","article-title":"Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets","volume":"10","author":"Gressner","year":"2006","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.bbrc.2020.09.142_bib2","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.bbrc.2020.09.142_bib3","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2020.09.142_bib4","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.bbalip.2013.08.002","article-title":"Pathological roles of ceramide and its metabolites in metabolic syndrome and Alzheimer\u2019s disease","volume":"1841","author":"Yuyama","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2020.09.142_bib5","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.tem.2015.07.006","article-title":"Ceramides - lipotoxic inducers of metabolic disorders","volume":"26","author":"Chaurasia","year":"2015","journal-title":"Trends. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2020.09.142_bib6","doi-asserted-by":"crossref","first-page":"32119","DOI":"10.1038\/srep32119","article-title":"Sphingosine kinase-1, S1P transporter spinster homolog 2 and S1P2 mRNA expressions are increased in liver with advanced fibrosis in human","volume":"6","author":"Sato","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2020.09.142_bib7","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jhep.2010.08.028","article-title":"Sphingosine 1-phosphate (S1P)\/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility","volume":"54","author":"Li","year":"2011","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.bbrc.2020.09.142_bib8","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.bbalip.2013.12.003","article-title":"The role of sphingomyelin and sphingomyelin synthases in cell death, proliferation and migration-from cell and animal models to human disorders","volume":"1841","author":"Taniguchi","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2020.09.142_bib9","doi-asserted-by":"crossref","first-page":"28544","DOI":"10.1074\/jbc.M111.255646","article-title":"Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes","volume":"286","author":"Mitsutake","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.09.142_bib10","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1161\/ATVBAHA.113.301498","article-title":"Sphingomyelin synthase 2 activity and liver steatosis: an effect of ceramide-mediated peroxisome proliferator-activated receptor \u03b32 suppression","volume":"33","author":"Li","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2020.09.142_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152191","article-title":"Imaging mass spectrometry reveals acyl-chain- and region-specific sphingolipid metabolism in the kidneys of sphingomyelin synthase 2-deficient mice","volume":"11","author":"Sugimoto","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.bbrc.2020.09.142_bib12","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.bbalip.2016.04.019","article-title":"Characterization of the role of sphingomyelin synthase 2 in glucose metabolism in whole-body and peripheral tissues in mice","volume":"1861","author":"Sugimoto","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2020.09.142_bib13","article-title":"Mouse models of nonalcoholic steatohepatitis in preclinical drug development","volume":"S1359\u20136446","author":"Hansen","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbrc.2020.09.142_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/iep.12008","article-title":"An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis","volume":"94","author":"Matsumoto","year":"2013","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.bbrc.2020.09.142_bib15","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.bbalip.2015.09.004","article-title":"Histological analyses by matrix-assisted laser desorption\/ionization-imaging mass spectrometry reveal differential localization of sphingomyelin molecular species regulated by particular ceramide synthase in mouse brains","volume":"1851","author":"Sugimoto","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2020.09.142_bib16","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1194\/jlr.R700019-JLR200","article-title":"Phosphatidylcholine and choline homeostasis","volume":"49","author":"Li","year":"2008","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.bbrc.2020.09.142_bib17","doi-asserted-by":"crossref","first-page":"18528","DOI":"10.1074\/jbc.M109.099333","article-title":"Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-L-methionine and glutathione","volume":"285","author":"Caballero","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.09.142_bib18","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hep.21655","article-title":"Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis","volume":"45","author":"Yamaguchi","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2020.09.142_bib19","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1074\/jbc.M807616200","article-title":"Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase","volume":"284","author":"Li","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.09.142_bib20","first-page":"151","article-title":"\u03b2-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model","volume":"7","author":"Zigmond","year":"2014","journal-title":"J.\u00a0Inflamm. Res."},{"key":"10.1016\/j.bbrc.2020.09.142_bib21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bbalip.2012.06.008","article-title":"Sphingosine-1-phosphate as a mediator involved in development of fibrotic diseases","volume":"1831","author":"Takuwa","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2020.09.142_bib22","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.bbalip.2013.08.014","article-title":"Sphingosine 1-phosphate is a key metabolite linking sphingolipids to glycerophospholipids","volume":"1841","author":"Kihara","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2020.09.142_bib23","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jhep.2013.02.021","article-title":"Sphingosine kinase\/sphingosine 1-phosphate (S1P)\/S1P receptor axis is involved in liver fibrosis-associated angiogenesis","volume":"59","author":"Yang","year":"2013","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.bbrc.2020.09.142_bib24","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/hep.29885","article-title":"Sphingosine kinase 1 promotes liver fibrosis by preventing miR-19b-3p-mediated inhibition of CCR2","volume":"68","author":"Lan","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2020.09.142_bib25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/biof.1342","article-title":"Inhibition of the SphK1\/S1P signaling pathway by melatonin in mice with liver fibrosis and human hepatic stellate cells","volume":"43","author":"Gonz\u00e1lez-Fern\u00e1ndez","year":"2017","journal-title":"Biofactors"},{"key":"10.1016\/j.bbrc.2020.09.142_bib26","doi-asserted-by":"crossref","first-page":"13423","DOI":"10.1038\/srep13423","article-title":"Sphingosine 1-phosphate receptor 2 and 3 mediate bone marrow-derived monocyte\/macrophage motility in cholestatic liver injury in mice","volume":"5","author":"Yang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2020.09.142_bib27","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1002\/jcp.22572","article-title":"Essential roles of sphingosine 1-phosphate receptor types 1 and 3 in human hepatic stellate cells motility and activation","volume":"226","author":"Liu","year":"2011","journal-title":"J.\u00a0Cell. Physiol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20319021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20319021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:41:57Z","timestamp":1762094517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X20319021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0006291X20319021"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.09.142","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sphingomyelin synthase 2 loss suppresses steatosis but exacerbates fibrosis in the liver of mice fed with choline-deficient, L-amino acid-defined, high-fat diet","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.09.142","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}